Nuformix (NFX) News Today → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free NFX Stock Alerts GBX 0.19 -0.01 (-3.00%) (As of 03:37 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsStock AnalysisChartCompetitors All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNuformix PLC NFXmorningstar.com - November 16 at 1:40 AMNuformix gets patent in Japan for pulmonary fibrosis treatment NXP002lse.co.uk - October 23 at 10:42 AMNuformix to fund its unlicensed programs with NXP001 windfallfinance.yahoo.com - October 5 at 8:59 AMCloud Village Inc (9899)uk.investing.com - July 25 at 10:11 AMK Seng Seng Corporation Bhd (KSSC)uk.investing.com - July 15 at 7:00 AMSuzumo Machinery Co Ltd (6405)uk.investing.com - July 14 at 10:57 AMENGAGE XR Holdings PLC (EXRE)uk.investing.com - July 13 at 2:33 AMNuformix raises GBP70,000 to fund NXP002 programmelse.co.uk - April 17 at 8:39 AMNuformix Raises GBP70,000 in Discount Share Subscriptionmarketwatch.com - April 17 at 8:39 AMNuformix Says Study Shows Effectiveness of New Lung-Disease Treatment Candidatemarketwatch.com - March 27 at 9:43 AMNuformix to Change Financial Year End to Sept. 30marketwatch.com - March 13 at 5:50 AMNuformix Shares Rise on Positive Olaparib Cancer Treatment Study Resultsmarketwatch.com - December 20 at 10:17 AMNuformix delighted as NXP004 testing exceeds its expectationsproactiveinvestors.com.au - December 20 at 10:17 AMNuformix interim loss virtually flat as continues work on drugslse.co.uk - December 13 at 5:49 PMNuformix to Start New NXP002 Study Program; Cancels Current Human IPF Tissue Studymarketwatch.com - September 23 at 9:47 AMLONDON MARKET EARLY CALL: Soft end to rocky week; UK retail sales duelse.co.uk - September 17 at 10:56 PMNuformix Shares Rise on Completion of Pre-Clinical Tolerability Studies for NXP002 Treatmentmarketwatch.com - August 10 at 1:30 PMNuformix 1H Pretax Loss Narrowed on Lower Costs; Shares Risemarketwatch.com - July 28 at 8:00 AMNuformix to Continue Investigating NXP002 Treatmentmarketwatch.com - June 27 at 8:06 AMNuformix Executive Chair Alastair Riddell resigns after one yearlse.co.uk - May 31 at 11:02 AMNuformix chairman resigns to take up new roleca.proactiveinvestors.com - May 31 at 5:16 AMNuformix Shares Drop After NXP002 Trial Results Were Inconsistent, Failure to Identify New Chiefmarketwatch.com - May 30 at 8:58 AMNuformix updates on NXP002, drug pipeline and CEO searchca.proactiveinvestors.com - May 30 at 8:58 AMNuformix will receive a gross £1.32mln from second tranche of Lanstead funding agreementproactiveinvestors.com - April 12 at 7:56 AMNuformix Shareholder Raises Stake to 16.6%marketwatch.com - April 5 at 6:36 PMNuformix Investor Subscription to Raise GBP1.7 Mln for Product Developmentmarketwatch.com - December 14 at 3:35 AMNuformix 1H Loss Narrowed Slightly on Lower Costsmarketwatch.com - December 14 at 3:35 AMNuformix Shares Rise on Positive Trial Studiesmarketwatch.com - November 25 at 8:06 AMNuformix Files New Patent Application for Cancer Treatmentmarketwatch.com - November 12 at 9:12 AMCORRECT: Nuformix Chair Alastair Riddell to move to executive chairlse.co.uk - November 9 at 2:30 PMChill Brands Share Chatlse.co.uk - October 21 at 11:41 PMLONDON BRIEFING: AB Foods says Primark sales growth hit by 'pingdemic'lse.co.uk - September 14 at 10:47 PMNuformix Shares Rise on Global Agreement for Cancer-Drug Licensemarketwatch.com - September 13 at 8:41 AMNo knee jerk reaction from Nuformix over CEO resignationproactiveinvestors.com - July 23 at 8:40 AMEXECUTIVE CHANGES: Nuformix responds to "frustration" as CEO departslse.co.uk - July 22 at 2:23 PM Get Nuformix News Delivered to You Automatically Sign up to receive the latest news and ratings for NFX and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide NFX Media Mentions By Week NFX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NFX News Sentiment▼0.000.37▲Average Medical News Sentiment NFX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NFX Articles This Week▼00▲NFX Articles Average Week Get Nuformix News Delivered to You Automatically Sign up to receive the latest news and ratings for NFX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PYC News RENE News EVG News FAB News OCTP News IXI News VAL News ROQ News BNR News IQAI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:NFX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuformix plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
